PL360404A1 - 3'-proleki 2'-dezoksy-beta-L-nukleozydów - Google Patents

3'-proleki 2'-dezoksy-beta-L-nukleozydów

Info

Publication number
PL360404A1
PL360404A1 PL36040401A PL36040401A PL360404A1 PL 360404 A1 PL360404 A1 PL 360404A1 PL 36040401 A PL36040401 A PL 36040401A PL 36040401 A PL36040401 A PL 36040401A PL 360404 A1 PL360404 A1 PL 360404A1
Authority
PL
Poland
Prior art keywords
prole
nucleosides
deoxy
beta
Prior art date
Application number
PL36040401A
Other languages
English (en)
Inventor
Martin L. Bryant
Gilles Gosselin
Jean-Louis Imbach
Original Assignee
Idenix (Cayman) Limited
Centre National De La Recherche Scientifique (Cnrs)
L'universite Montpellier Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idenix (Cayman) Limited, Centre National De La Recherche Scientifique (Cnrs), L'universite Montpellier Ii filed Critical Idenix (Cayman) Limited
Publication of PL360404A1 publication Critical patent/PL360404A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL36040401A 2000-06-15 2001-06-15 3'-proleki 2'-dezoksy-beta-L-nukleozydów PL360404A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21210000P 2000-06-15 2000-06-15
PCT/US2001/019147 WO2001096353A2 (en) 2000-06-15 2001-06-15 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES

Publications (1)

Publication Number Publication Date
PL360404A1 true PL360404A1 (pl) 2004-09-06

Family

ID=22789563

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36040401A PL360404A1 (pl) 2000-06-15 2001-06-15 3'-proleki 2'-dezoksy-beta-L-nukleozydów

Country Status (28)

Country Link
EP (1) EP1296995B1 (pl)
JP (1) JP4639032B2 (pl)
KR (2) KR20030032967A (pl)
CN (3) CN101012259A (pl)
AP (1) AP1771A (pl)
AR (1) AR035711A1 (pl)
AT (1) ATE411332T1 (pl)
AU (2) AU2001266927B2 (pl)
BR (1) BR0111732A (pl)
CA (1) CA2413163C (pl)
CZ (1) CZ2003122A3 (pl)
DE (1) DE60136181D1 (pl)
EA (1) EA005774B1 (pl)
ES (1) ES2317912T3 (pl)
IL (3) IL153379A0 (pl)
MA (1) MA27126A1 (pl)
MX (1) MXPA02012443A (pl)
MY (1) MY141594A (pl)
NO (1) NO20026001L (pl)
NZ (2) NZ535246A (pl)
OA (1) OA12384A (pl)
PE (1) PE20020216A1 (pl)
PL (1) PL360404A1 (pl)
PY (1) PY0114386A (pl)
UY (1) UY26779A1 (pl)
WO (1) WO2001096353A2 (pl)
YU (1) YU94802A (pl)
ZA (2) ZA200300168B (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532643A (ja) 2000-04-13 2003-11-05 フアーマセツト・リミテツド 肝炎ウイルス感染症を治療するための３’−または２’−ヒドロキシメチル置換ヌクレオシド誘導体
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
US6787526B1 (en) 2000-05-26 2004-09-07 Idenix Pharmaceuticals, Inc. Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
PL359169A1 (pl) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Sposoby i kompozycje do leczenia infekcji flawiwirusowych i pestiwirusowych
AU2002330154A1 (en) 2001-09-28 2003-04-07 Centre National De La Recherche Scientifique Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
AU2003247084B9 (en) * 2002-06-28 2018-07-26 Centre National De La Recherche Scientifique Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
KR20050035194A (ko) 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-ｃ-메틸-3'-ｏ-ｌ-발린에스테르 리보푸라노실 사이티딘
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
KR20050055630A (ko) * 2002-06-28 2005-06-13 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
SI1572095T1 (sl) 2002-09-13 2015-12-31 Novartis Ag Beta-l-2'-deoksinukleozidi za uporabo pri zdravljenju odpornih sevov hbv
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
US7582748B2 (en) 2003-03-20 2009-09-01 Microbiologica Quimica E Farmaceutical Ltd. Methods of manufacture of 2′-deoxy-β-L-nucleosides
KR20060015542A (ko) 2003-04-28 2006-02-17 이데닉스 (케이만) 리미티드 산업 규모의 뉴클레오시드 합성
RU2358979C2 (ru) 2003-05-30 2009-06-20 Фармассет, Инк. Модифицированные фторированные аналоги нуклеозида
US20050059632A1 (en) 2003-06-30 2005-03-17 Richard Storer Synthesis of beta-L-2'-deoxy nucleosides
US7754718B2 (en) 2004-05-05 2010-07-13 Yale University Antiviral helioxanthin analogs
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
ES2725457T3 (es) 2004-09-14 2019-09-24 Gilead Pharmasset Llc Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
RU2427372C2 (ru) 2005-06-17 2011-08-27 Новартис Аг Применение санглиферина для лечения вируса гепатита с
GB0609178D0 (en) * 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
AU2009257369B2 (en) 2008-06-11 2015-03-26 Agilent Technologies, Inc. Nucleotides and nucleosides and methods for their use in DNA sequencing
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
MX2011006890A (es) 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
TWI515000B (zh) 2010-04-01 2016-01-01 伊迪尼克製藥公司 用於治療病毒感染之化合物及醫藥組合物
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
AU2012308900A1 (en) 2011-09-12 2013-05-09 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
EP3670523B1 (en) 2011-09-13 2021-08-11 Agilent Technologies, Inc. 3'-oh unblocked, fast photocleavable terminating nucleotides and their use in methods for nucleic acid sequencing
HRP20180237T4 (hr) 2011-09-16 2020-12-11 Gilead Pharmasset Llc Metode za liječenje hcv-a
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
AR090699A1 (es) * 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
EP2950786B1 (en) 2013-01-31 2019-11-27 Gilead Pharmasset LLC Combination formulation of two antiviral compounds
EA201690473A1 (ru) 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
IL277725B2 (en) 2018-04-12 2024-02-01 Modis Therapeutics Inc Pro-drugs of deoxynucleosides for the treatment of diseases resulting from an imbalance in the nucleotide reserves
CN116574146B (zh) * 2023-05-18 2026-05-29 沈阳农业大学 具有抗马铃薯y病毒属病毒活性的化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
SE505648C2 (sv) * 1996-08-30 1997-09-22 Scania Cv Ab Anordning vid ett fordon för monterbar anfästning av en förarplatsmodul
US6395716B1 (en) * 1998-08-10 2002-05-28 Novirio Pharmaceuticals Limited β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

Also Published As

Publication number Publication date
EP1296995A2 (en) 2003-04-02
EA200300023A1 (ru) 2003-08-28
PE20020216A1 (es) 2002-04-16
AP2003002713A0 (en) 2003-03-31
CA2413163A1 (en) 2001-12-20
CN1900104A (zh) 2007-01-24
KR20070048277A (ko) 2007-05-08
MXPA02012443A (es) 2004-09-10
ATE411332T1 (de) 2008-10-15
CA2413163C (en) 2008-11-18
AU6692701A (en) 2001-12-24
NO20026001D0 (no) 2002-12-13
WO2001096353A3 (en) 2002-04-18
EA005774B1 (ru) 2005-06-30
PY0114386A (es) 2004-04-01
CN101012259A (zh) 2007-08-08
AU2001266927B2 (en) 2006-12-14
EP1296995B1 (en) 2008-10-15
MY141594A (en) 2010-05-14
MA27126A1 (fr) 2005-01-03
BR0111732A (pt) 2003-06-24
YU94802A (sh) 2006-03-03
OA12384A (en) 2006-04-17
JP4639032B2 (ja) 2011-02-23
IL153379A0 (en) 2003-07-06
NZ535246A (en) 2006-06-30
KR20030032967A (ko) 2003-04-26
NO20026001L (no) 2003-02-12
CN1452627A (zh) 2003-10-29
AP1771A (en) 2007-08-23
ZA200404306B (en) 2005-06-15
ES2317912T3 (es) 2009-05-01
WO2001096353A2 (en) 2001-12-20
IL178864A0 (en) 2007-03-08
JP2004533403A (ja) 2004-11-04
ZA200300168B (en) 2004-07-07
CN1295242C (zh) 2007-01-17
UY26779A1 (es) 2001-12-28
IL153379A (en) 2007-02-11
AR035711A1 (es) 2004-07-07
NZ523632A (en) 2005-03-24
DE60136181D1 (de) 2008-11-27
CZ2003122A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
NO20031268D0 (no) 4-aminokinazoliner
ATE290000T1 (de) Muscarinagonisten
NO20002137D0 (no) ReservoarovervÕkning
NO20031498D0 (no) Ftalazinonderivater
DZ3409A1 (fr) Association therapeuthique
ATA2932001A (de) Schneefräse
DE50114386D1 (de) Ng
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
NO20031267L (no) 4-aminokinazoliner
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
DE50113112D1 (de) Schaltungsanordnung
ATE476423T1 (de) Benzoylpyridazine
AR027982A1 (es) Aril- y heteroarilsulfonatos
EP1192168A4 (en) galectin
EP1314428A4 (en) OCT PREPARATIONS
ATE284887T1 (de) Thienopyrrolidinone
ATA7092001A (de) Skibindungseinstellgerät
AT500246B8 (de) Chokerring
FR2815159B1 (fr) Panneau d'affichage
DE50115426D1 (de) Schaltungsanordnung
FR2817889B1 (fr) Coffrage
ITRC20000004V0 (it) Deodorante - souvenir "i calandreddhi"

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)